RecruitingPhase 3NCT07181109Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseSponsor: Alnylam PharmaceuticalsAllen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 3NCT06822738A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With GlaucomaSponsor: AbbVieDallas, TX · El Paso, TX · +26 more sites
RecruitingNot applicableNCT04553523Hydrus® Microstent New Enrollment Post-Approval StudySponsor: Alcon ResearchAustin, TX · Dallas, TX · El Paso, TX · +19 more sites
RecruitingPhase 2NCT07075718Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantSponsor: Glaukos CorporationEl Paso, TX · +2 more sites